drugset / Trial / NCT02491541
A Phase 3 Clinical Trial for a Rabies Vaccine (Vero Cell) for Human Use in Healthy Chinese Subjects
RandomizedParallel-groupDouble-blindPrevention
Summary
The purpose of this single-centre, randomized, double-blind, parallel control, phase 3 study is to evaluate the safety and immunogenicity of a rabies vaccine (Vero Cell) for human use in healthy Chinese subjects aged 10-60 years, according to the Essen methods (1-1-1-1-1) vaccination.
Timeline
- Start
- 2012-08
- Primary completion
- 2012-12
- Completion
- 2013-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Changchun Werersai | Unknown | 1 ml | — |
| Comparator | Jilin Maifeng | Unknown | 1 ml | — |